We analyzed the correlation between subtype and clinicopathologic features, and further investigated the expression of AFP, vascular endothelial growth factor (VEGF), and CEA in these tumor tissues using immunohistochemistry. The gene discussed is CEACAM5; the disease is neoplasm.